Therapeutic neuromodulation for treatment of schizophrenia

Jeffrey T. Rado*, Edgar I. Hernandez

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter


While antipsychotics are the mainstay of treatment for schizophrenia, many patients do not achieve an adequate response. Indeed, a significant percentage are refractory to medication, including the most effective agent available, clozapine. As a result, there is a need for alternative treatments which are both effective and safe. Therapeutic neuromodulation includes such approaches as electroconvulsive therapy, transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain stimulation and represents a growing field of study for refractory symptoms. This chapter discusses the potential role of such device-based therapies in schizophrenia.

Original languageEnglish (US)
Title of host publicationSchizophrenia
Subtitle of host publicationRecent Advances in Diagnosis and Treatment
PublisherSpringer New York
Number of pages22
ISBN (Electronic)9781493906567
ISBN (Print)1493906550, 9781493906550
StatePublished - Feb 1 2014

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Therapeutic neuromodulation for treatment of schizophrenia'. Together they form a unique fingerprint.

Cite this